Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Taro Pharmaceutical Indus...

    NYSE: TARO · Real-Time Price · USD
    42.98
    0.01 (0.02%)
    At close: Jun 21, 2024, 9:59 PM

    Taro Pharmaceutical Industries Statistics

    Share Statistics

    Taro Pharmaceutical Industries has 37.58M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 37.58M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 12.42%

    Shares Floating

    n/a
    		 8.09M

    Failed to Deliver (FTD) Shares

    n/a
    		 14,573

    FTD / Avg. Volume

    n/a
    		 44.26%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 29.47 and the forward PE ratio is null. Taro Pharmaceutical Industries's PEG ratio is 0.27.

    PE Ratio

    n/a
    		 29.47

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 2.52

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.89

    P/FCF Ratio

    n/a
    		 20.3

    PEG Ratio

    n/a
    		 0.27
    Financial Ratio History

    Enterprise Valuation

    Taro Pharmaceutical Industries has an Enterprise Value (EV) of 1.22B.

    EV / Sales

    n/a
    		 1.95

    EV / EBITDA

    n/a
    		 31.88

    EV / EBIT

    n/a
    		 9.25

    EV / FCF

    n/a
    		 15.66

    Financial Position

    The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 3.61

    Quick Ratio

    n/a
    		 3.04

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 3% and Return on Invested Capital is 0.78%.

    Return on Equity

    n/a
    		 3%

    Return on Assets

    n/a
    		 2.49%

    Return on Invested Capital

    n/a
    		 0.78%

    Revenue Per Employee

    n/a
    		 $404,879.02

    Profits Per Employee

    n/a
    		 $34,663.45

    Employee Count

    n/a
    		 1,554

    Asset Turnover

    n/a
    		 0.29

    Inventory Turnover

    n/a
    		 1.58

    Taxes

    Income Tax

    n/a
    		 28.8M

    Effective Tax Rate

    n/a
    		 34.84%

    Stock Price Statistics

    The stock price has increased by 1.85% in the last 52 weeks. The beta is 0.56, so Taro Pharmaceutical Industries's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.56

    52-Week Price Change

    n/a
    		 1.85%

    50-Day Moving Average

    n/a
    		 42.5

    200-Day Moving Average

    n/a
    		 40.2

    Relative Strength Index (RSI)

    n/a
    		 64.79

    Average Volume (20 Days)

    n/a
    		 32,927

    Income Statement

    In the last 12 months, Taro Pharmaceutical Industries had revenue of 629.18M and earned 53.87M in profits. Earnings per share was 1.43.

    Revenue

    n/a
    		 629.18M

    Gross Profit

    n/a
    		 304.98M

    Operating Income

    n/a
    		 21.51M

    Net Income

    n/a
    		 53.87M

    EBITDA

    n/a
    		 38.4M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 1.43
    Full Income Statement

    Balance Sheet

    The company has 362.91M in cash and 0 in debt, giving a net cash position of 362.91M.

    Cash & Cash Equivalents

    n/a
    		 362.91M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 n/a

    Total Assets

    n/a
    		 2.16B

    Working Capital

    n/a
    		 942.3M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 132.39M and capital expenditures -54.22M, giving a free cash flow of 78.17M.

    Operating Cash Flow

    n/a
    		 132.39M

    Capital Expenditures

    n/a
    		 -54.22M

    Free Cash Flow

    n/a
    		 78.17M

    FCF Per Share

    n/a
    		 2.08
    Full Cash Flow Statement

    Margins

    Gross margin is 48.47%, with operating and profit margins of 3.42% and 8.56%.

    Gross Margin

    n/a
    		 48.47%

    Operating Margin

    n/a
    		 3.42%

    Pretax Margin

    n/a
    		 13.14%

    Profit Margin

    n/a
    		 8.56%

    EBITDA Margin

    n/a
    		 6.1%

    EBIT Margin

    n/a
    		 3.42%

    FCF Margin

    n/a
    		 12.42%

    Dividends & Yields

    TARO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 3.39%

    FCF Yield

    n/a
    		 4.92%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for TARO.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 27, 2001. It was a forward split with a ratio of 2:1.

    Last Split Date

    n/a
    		 Jul 27, 2001

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 2:1

    Scores

    Altman Z-Score

    n/a
    		 3.49

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist